286 related articles for article (PubMed ID: 14706337)
1. Requirement for cyclin D3 in lymphocyte development and T cell leukemias.
Sicinska E; Aifantis I; Le Cam L; Swat W; Borowski C; Yu Q; Ferrando AA; Levin SD; Geng Y; von Boehmer H; Sicinski P
Cancer Cell; 2003 Dec; 4(6):451-61. PubMed ID: 14706337
[TBL] [Abstract][Full Text] [Related]
2. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
3. No T without D3: a critical role for cyclin D3 in normal and malignant precursor T cells.
Weng AP; Aster JC
Cancer Cell; 2003 Dec; 4(6):417-8. PubMed ID: 14706330
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
5. Mouse development and cell proliferation in the absence of D-cyclins.
Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P
Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760
[TBL] [Abstract][Full Text] [Related]
6. The cyclin D3 knockout: a pound of redundancy with a dash of tissue specificity.
Diehl JA
Cancer Biol Ther; 2004 Feb; 3(2):162-4. PubMed ID: 14752277
[TBL] [Abstract][Full Text] [Related]
7. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
8. Development of mice expressing a single D-type cyclin.
Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P
Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747
[TBL] [Abstract][Full Text] [Related]
9. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, or D3 but not by a mutant cyclin D1.
Lahti JM; Li H; Kidd VJ
J Biol Chem; 1997 Apr; 272(16):10859-69. PubMed ID: 9099742
[TBL] [Abstract][Full Text] [Related]
10. Essential role for cyclin D3 in granulocyte colony-stimulating factor-driven expansion of neutrophil granulocytes.
Sicinska E; Lee YM; Gits J; Shigematsu H; Yu Q; Rebel VI; Geng Y; Marshall CJ; Akashi K; Dorfman DM; Touw IP; Sicinski P
Mol Cell Biol; 2006 Nov; 26(21):8052-60. PubMed ID: 16954383
[TBL] [Abstract][Full Text] [Related]
11. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
12. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
13. Genetic replacement of cyclin D1 function in mouse development by cyclin D2.
Carthon BC; Neumann CA; Das M; Pawlyk B; Li T; Geng Y; Sicinski P
Mol Cell Biol; 2005 Feb; 25(3):1081-8. PubMed ID: 15657434
[TBL] [Abstract][Full Text] [Related]
14. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
15. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
[TBL] [Abstract][Full Text] [Related]
16. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
[TBL] [Abstract][Full Text] [Related]
19. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
[TBL] [Abstract][Full Text] [Related]
20. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
